Invesco Announces Third Quarter Diluted EPS of $0.66; Adjusted Diluted EPS(1) of $0.61 ATLANTA , Oct. 28, 2025 /PRNewswire/ -- Invesco Ltd. (NYSE: IVZ) today reported financial results for the three months ended September 30, 2025.
We purchased several new fund holdings across various sectors. Sempra has been shifting its strategic focus from its highly regulated California operations to its growing presence in Texas. Regeneron in our view has a strong balance sheet and a robust product pipeline.
For income investors with a smaller amount of new money to put to work, going for some of the lower-priced stocks could make a lot of sense, especially if one's brokerage doesn't allow for the purchase of partial shares.
ATLANTA , Oct. 9, 2025 /PRNewswire/ -- Invesco Ltd. (NYSE: IVZ)1 today reported preliminary month-end assets under management (AUM) of $2,124.8 billion, an increase of 3.0% versus previous month-end.
ATLANTA , Oct. 7, 2025 /PRNewswire/ -- Invesco Ltd. (NYSE: IVZ), a leading global asset management firm, today announced the completion of the first initiative in its strategic partnership with Barings, signaling its commitment to delivering differentiated private markets solutions to investors.
Invesco Ltd. shares have outperformed the S&P 500, delivering a 106% total return since October 2023. IVZ's strong performance is attributed to rising markets, solid business results, QQQ fund conversion prospects, and valuation multiple expansion. Assets under management have grown from $1.49 trillion at the time of my prior piece to $2.06 trillion today, with adjusted operating margin improve...
Kostenlos registrieren
aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.